Description: Recombinant human Insulin produced in yeast has been biotinylated using our biotinylation technology that was developped for IGF`s and analogs. Formulation: Lyophilised from a solution of 0.5 ml TBS, pH 7.4, containing 100 μg of the biotinylated product . A preservative and a stabilising protein of non-mammalian origin are added to ensure stability of the reconstituted product.